Article
Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agent.
Mutation research - 1 Jun 1994
Hirai O, Miyamae Y, Hattori Y, Takashima M, Miyamoto A, Zaizen K, Mine Y
Abstract excerpt
The genotoxic activity of a new antitumor agent, FK973, was compared with that of mitomycin C (MMC) in eukaryotic and prokaryotic cells. In chromosome aberration tests using Chinese hamster fibroblast Don cells, FK973 induced a dose-related increase of aberrant cells after 6 h-pulse treatments, and the minimum effective concentrations with and without S9 were 0.625 and 0.0625 micrograms/ml, respectively. The...
Topics
- Animals
- Antineoplastic Agents
- Biotransformation
- Cells, Cultured
- Chromosome Aberrations
- Cricetinae
- Cricetulus
- Mitomycin
- Mutagenicity Tests
- Mutation
- Oxazines
